PNPLA6 Antikörper (AA 345-493)
-
- Target Alle PNPLA6 Antikörper anzeigen
- PNPLA6 (Patatin-Like phospholipase Domain Containing 6 (PNPLA6))
-
Bindungsspezifität
- AA 345-493
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PNPLA6 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Neuropathy target esterase protein (345-493AA)
- Isotyp
- IgG
- Top Product
- Discover our top product PNPLA6 Primärantikörper
-
anti-Patatin-Like phospholipase Domain Containing 6 (PNPLA6) (Internal Region) antibody
PNPLA6 Reaktivität: Human, Maus, Ratte WB, ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Patatin-Like phospholipase Domain Containing 6 (PNPLA6) (AA 1229-1327) antibodyPNPLA6 Reaktivität: Human WB, ELISA, IHC (p) Wirt: Maus Monoclonal 3D10 unconjugated
anti-Patatin-Like phospholipase Domain Containing 6 (PNPLA6) (N-Term) antibodyPNPLA6 Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Patatin-Like phospholipase Domain Containing 6 (PNPLA6) (N-Term) antibodyPNPLA6 Reaktivität: Human, Maus WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Patatin-Like phospholipase Domain Containing 6 (PNPLA6) (Internal Region) antibodyPNPLA6 Reaktivität: Human, Maus WB, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Patatin-Like phospholipase Domain Containing 6 (PNPLA6) (C-Term) antibodyPNPLA6 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Meerschweinchen, Pferd, Kaninchen, Schwein, Fledermaus, Affe WB Wirt: Kaninchen Polyclonal unconjugated
anti-Patatin-Like phospholipase Domain Containing 6 (PNPLA6) (C-Term) antibodyPNPLA6 Reaktivität: Zebrafisch (Danio rerio), Fisch WB, IHC, IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Patatin-Like phospholipase Domain Containing 6 (PNPLA6) (AA 965-1137) antibodyPNPLA6 Reaktivität: Ratte WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Recommended dilution: IHC:1:500-1:1000, IF:1:50-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- PNPLA6 (Patatin-Like phospholipase Domain Containing 6 (PNPLA6))
- Andere Bezeichnung
- PNPLA6 (PNPLA6 Produkte)
- Synonyme
- NTE antikoerper, NTEMND antikoerper, SPG39 antikoerper, iPLA2delta antikoerper, sws antikoerper, AI661849 antikoerper, MSws antikoerper, Nte antikoerper, RGD1564611 antikoerper, wu:fy20f06 antikoerper, patatin like phospholipase domain containing 6 antikoerper, patatin-like phospholipase domain containing 6 antikoerper, PNPLA6 antikoerper, Pnpla6 antikoerper, pnpla6 antikoerper
- Hintergrund
-
Background: Phospholipase B that deacylates intracellular phosphatidylcholine (PtdCho), generating glycerophosphocholine (GroPtdCho). This deacylation occurs at both sn-2 and sn-1 positions of PtdCho. Its specific chemical modification by certain organophosphorus (OP) compounds leads to distal axonopathy.
Aliases: EC 3.1.1.5 antibody, Neuropathy target esterase antibody, NTEMND antibody, Patatin like phospholipase domain containing 6 antibody, Patatin like phospholipase domain containing protein 6 antibody, Patatin-like phospholipase domain-containing protein 6 antibody, PLPL6_HUMAN antibody, Pnpla6 antibody, SPG39 antibody, sws antibody
- UniProt
- Q8IY17
- Pathways
- Ribonucleoside Biosynthetic Process
-
